Pharmacogenomics of Central Nervous System (CNS) Drugs-Reference-Cited by-同舟云学术

Pharmacogenomics of Central Nervous System (CNS) Drugs

Published:2012-10-18 Issue:8 Volume:73 Page:461-476
ISSN:0272-4391
Container-title:Drug Development Research
language:en
Short-container-title:Drug Dev. Res.

Author:

Cacabelos Ramón¹

Affiliation:

1. EuroEspes Biomedical Research Center; Institute for CNS Disorders and Genomic Medicine; EuroEspes Chair of Biotechnology and Genomics, Camilo José Cela University; Bergondo; Corunna; Spain

Publisher

Wiley

Subject

Drug Discovery

Reference41 articles.

1. RNA interference: biology, mechanism, and applications;Agrawal;Microbiol Mol Biol Rev,2003

2. Alzgene.org Alzheimer Research Forum 2012 http://www.alzgene.org

3. High throughput protein expression screening in the nervous system-needs and limitations;Anderson;J Physiol,2006

4. Rational design of therapeutic siRNAs: minimizing off-targeting potential to improve the safety of RNAi therapy for Huntington's disease;Boudreau;Mol Ther,2011

5. Pharmacogenomics and therapeutic prospects in Alzheimer's disease;Cacabelos;Exp Opin Pharmacother,2005

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Utility of pharmacogenetic testing to optimise antidepressant pharmacotherapy in youth: a narrative literature review;Frontiers in Pharmacology;2023-09-19

2. CONTROL OF THE PHARMACOGENETICS OF ENZYMES’ MEDICINE BIOTRANSFORMATION – A TOOL FOR PROVIDING PERSONALIZED MEDICINE;Bulletin of Problems Biology and Medicine;2023

3. Personalized Management and Treatment of Alzheimer’s Disease;Life;2022-03-21

4. Pharmacogenomics of Alzheimer’s Disease: Novel Strategies for Drug Utilization and Development;Methods in Molecular Biology;2022

5. Behavioral Symptoms of Dementia in Latinos: Pharmacological, Non-pharmacological, and Ethnocultural Healthcare Interventions;Caring for Latinxs with Dementia in a Globalized World;2020